Page last updated: 2024-09-04

sk&f 83959 and Atherosclerotic Parkinsonism

sk&f 83959 has been researched along with Atherosclerotic Parkinsonism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andringa, G; Cools, AR; Drukarch, B; Stoof, JC; Vermeulen, RJ	1

Other Studies

1 other study(ies) available for sk&f 83959 and Atherosclerotic Parkinsonism

Article	Year
Dopamine receptor subtypes as targets for the pharmacotherapy of Parkinson's disease. Advances in pharmacology (San Diego, Calif.), 1998, Volume: 42 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Benzazepines; Dopamine Agonists; Haplorhini; Levodopa; Motor Activity; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1	1998

Article

Year

Dopamine receptor subtypes as targets for the pharmacotherapy of Parkinson's disease.

Advances in pharmacology (San Diego, Calif.), 1998, Volume: 42

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Benzazepines; Dopamine Agonists; Haplorhini; Levodopa; Motor Activity; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1

1998